| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Department of Molecular Biology, The Scripps Research Institute, La Jolla California; 2 Cancer Center Karolinska, Karolinska Sjukhuset, Department of Oncology/Pathology, Stockholm, Sweden; and 3 Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California
hCDC4, the gene that encodes the F-box protein responsible for targeting cyclin E for ubiquitin-mediated proteolysis, has been found to be mutated in a number of primary cancers and cancer-derived cell lines. We have observed that functional inactivation of hCDC4 does not necessarily correlate with elevated levels of cyclin E in tumors. Here we show, however, that hCDC4 mutation in primary tumors correlates strongly with loss of cell cycle regulation of cyclin E. Similarly, a breast carcinoma-derived cell line mutated for hCDC4 exhibits cell cycle deregulation of cyclin E, but periodic expression is restored by reintroducing hCDC4 via retroviral transduction. Conversely, small interfering RNA-mediated silencing of hCdc4 deregulates cyclin E with respect to the cell cycle. These results indicate that hCdc4 function is an absolute prerequisite for cell cycle regulation of cyclin E levels, and loss of hCdc4 function is sufficient to deregulate cyclin E.
This article has been cited by other articles:
|
|
 |
|
  J. E. Grim, M. P. Gustafson, R. K. Hirata, A. C. Hagar, J. Swanger, M. Welcker, H. C. Hwang, J. Ericsson, D. W. Russell, and B. E. Clurman Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase J. Cell Biol., October 21, 2008; 181(6): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Minella, K. R. Loeb, A. Knecht, M. Welcker, B. J. Varnum-Finney, I. D. Bernstein, J. M. Roberts, and B. E. Clurman Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo Genes & Dev., June 15, 2008; 22(12): 1677 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Stallings, Y. X. Zeng, F. Narvaez, and M. J. Rebecchi Phospholipase C-{delta}1 Expression Is Linked to Proliferation, DNA Synthesis, and Cyclin E Levels J. Biol. Chem., May 16, 2008; 283(20): 13992 - 14001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsuoka, Y. Oike, I. Onoyama, A. Iwama, F. Arai, K. Takubo, Y. Mashimo, H. Oguro, E. Nitta, K. Ito, et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL Genes & Dev., April 15, 2008; 22(8): 986 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Onoyama, R. Tsunematsu, A. Matsumoto, T. Kimura, I. M. de Alboran, K. Nakayama, and K. I. Nakayama Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis J. Exp. Med., November 26, 2007; 204(12): 2875 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Keck, M. K. Summers, D. Tedesco, S. Ekholm-Reed, L.-C. Chuang, P. K. Jackson, and S. I. Reed Cyclin E overexpression impairs progression through mitosis by inhibiting APCCdh1 J. Cell Biol., July 24, 2007; 178(3): 371 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ma, S. Fiering, C. Black, X. Liu, Z. Yuan, V. A. Memoli, D. J. Robbins, H. A. Bentley, G. J. Tsongalis, E. Demidenko, et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas PNAS, March 6, 2007; 104(10): 4089 - 4094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang and D. M. Koepp Fbw7 Isoform Interaction Contributes to Cyclin E Proteolysis Mol. Cancer Res., December 1, 2006; 4(12): 935 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Potemski, E. Pluciennik, A. K. Bednarek, R. Kusinska, D. Jesionek-Kupnicka, G. Pasz-Walczak, C. Watala, and R. Kordek Cyclin E Expression in Operable Breast Cancer Quantified Using Real-Time RT-PCR: A Comparative Study with Immunostaining Jpn. J. Clin. Oncol., March 1, 2006; 36(3): 142 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Kemp, A. Rowan, W. Chambers, N. Wortham, S. Halford, O. Sieber, N. Mortensen, A. von Herbay, T. Gunther, M. Ilyas, et al. CDC4 Mutations Occur in a Subset of Colorectal Cancers but Are Not Predicted to Cause Loss of Function and Are Not Associated with Chromosomal Instability Cancer Res., December 15, 2005; 65(24): 11361 - 11366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Reed Deregulation of Cyclin E in Cancer Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 53 - 56. [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Schneider and M. Kulesz-Martin Destructive cycles: the role of genomic instability and adaptation in carcinogenesis Carcinogenesis, November 1, 2004; 25(11): 2033 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ekholm-Reed, J. Mendez, D. Tedesco, A. Zetterberg, B. Stillman, and S. I. Reed Deregulation of cyclin E in human cells interferes with prereplication complex assembly J. Cell Biol., June 21, 2004; 165(6): 789 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Welcker, A. Orian, J. Jin, J. E. Grim, J. W. Harper, R. N. Eisenman, and B. E. Clurman From The Cover: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation PNAS, June 15, 2004; 101(24): 9085 - 9090. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
